Snowball logo
logo
UTMD_logo

Utah Medical Products Inc

UTMD โ€ข NASDAQ
$72.00+$1.79ย  (2.55%)
Estimate
P/E
22
EPS
3.28
Beta
0.363
Growth
Revenue, YoY
-14.31%
Net income, YoY
-11.88%
Dividends
Dividend yield
1.72%
Annual payout
$1.24
Next ex. div date
September 17, 26
Payout
35.29%
Div.growth, 5y
-15.36%
Dividend growth streak
3 y
Div.rating
About the company
Ticker
UTMD
ISIN
US9174881089
Country
United States of America
Sector (GICS)
Healthcare
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Frequently asked questions

What sector does Utah Medical Products Inc (UTMD) operate in?

Utah Medical Products Inc belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is Utah Medical Products Inc (UTMD) current stock price?

As of the latest data, Utah Medical Products Inc stock price is $72.00, with a previous close of $70.21. Utah Medical Products Inc gained $1.79 in the last trading session, representing a 2.55% increase.

What is Utah Medical Products Inc (UTMD) current market capitalization?

Utah Medical Products Inc market cap is approximately 229.25 million.

What is Utah Medical Products Inc (UTMD) Earnings Per Share (EPS)?

The trailing EPS is $3.28.

What is Utah Medical Products Inc (UTMD) Price-to-Earnings (P/E) ratio?

Utah Medical Products Inc current P/E ratio is 21.95.

What is Utah Medical Products Inc (UTMD) EBITDA?

Utah Medical Products Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 2.88 million.

Does Utah Medical Products Inc (UTMD) pay dividends?

Yes. Utah Medical Products Inc pays quarterly dividends with an annualized yield of 1.72% and an estimated annual payout of $1.24 per share.

When is the next ex-dividend date for Utah Medical Products Inc (UTMD)?

The next ex-dividend date is scheduled for September 17, 2026.

When is Utah Medical Products Inc (UTMD) next earnings report?

Utah Medical Products Inc is expected to release its next earnings report on September 30, 2026.

What is Utah Medical Products Inc (UTMD) beta (volatility) score?

Utah Medical Products Inc has a beta of 0.363, indicating lower volatility than the overall market.